Epstein-Barr virus-associated carcinomas: Facts and fiction

Journal of Pathology

Volumn 199, Issue 2, 2003, Pages 140-145

  Herrman, Kathrin ^a   Niedobitek, Gerald ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Breast carcinoma; Cervical carcinoma; Epstein Barr virus; Gastric carcinoma; Hepatocellular carcinoma; Lymphoepothelial carcinomas; Nasopharyngeal carcinoma

Indexed keywords

VIRUS DNA;

BREAST CARCINOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CARCINOGENESIS; CARCINOMA; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; IN SITU HYBRIDIZATION; INCIDENCE; LIVER CELL CARCINOMA; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; VIRUS DETECTION; VIRUS LATENCY;

BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; DNA, VIRAL; EPITHELIUM; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LYMPHOMA; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; RNA, NEOPLASM; RNA, VIRAL; STOMACH NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 0037314313     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1296     Document Type: Review

References (62)

1. International Agency for Research on Cancer. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8, vol 70. WHO: Lyon, 1997.
2. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995; 55: 39-45.
3. Sugawara Y, Mizugaki Y, Uchida T, et al. Detection of Epstein Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999; 256: 196-202.
4. Ambinder RF, Robertson KD, Moore SM, Yang J. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Sent Cancer Biol 1996; 7: 217-226.
5. Roskrow MA, Suzuki N, Gan Y-J, et al. Epstein-Barr virus (EBV)-specific cytotoxic lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 1998; 91: 2925-2934.
6. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883-889.
7. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO J 1987; 6: 2743-2751.
8. Rowe M, Lear A, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus (EBV) gene activation from EBNA1-positive latency in B lymphocytes. J Virol 1992; 66: 122-131.
9. Niedobitek G, Agathanggelou A, Rowe M, et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995; 86: 659-665.
10. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A 1991; 88: 4766-4770.
11. Niedobitek G, Kremmer E, Herbst H, et al. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in Hodgkin's disease and infectious mononucleosis. Blood 1997; 90: 1664-1672.
12. Niedobitek G, Mutimer DJ, Williams A, et al. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients. Int J Cancer 1997; 73: 514-520.
13. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol 1997; 182: 151-159.
14. Nicholls JM. Nasopharyngeal carcinoma: classification and histological appearances. Adv Anat Pathol 1997; 4: 71-84.
15. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 1966; 56: 1699-1704.
16. Zur Hansen H, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (London) 1970; 228: 1056-1058.
17. Wolf H, zur Hausen H, Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature (London) 1973; 244: 245-247.
18. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974; 71: 4737-4741.
19. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992; 140: 879-887.
20. Henle W, Henle G, Ho H-C, et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970; 44: 225-231.
21. Micheau C. What's new in histological classification and recognition of naso-pharyngeal carcinoma (NPC). Pathol Res Pract 1986; 181: 249-253.
22. Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165: 17-24.
23. Niedobitek G, Agathanggelou A, Barber P, Smallman LA, Jones EL, Young LS. p53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 1993; 170: 457-461.
24. Hording U, Nielsen HW, Albeck H, Daugaard S. Nasopharyngeal carcinoma - histopathological types and association with Epstein-Barr virus. Eur J Cancer B Oral Oncol 1993; 298: 137-139.
25. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987; 39: 25-29.
26. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, non-keratinising, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355-1367.
27. Nicholls JM, Agathanggelou A, Fung K, Xianggou Z, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographic variation reminiscent of Burkitt's lymphoma. J Pathol 1997; 183: 164-168.
28. Niedobitek G, Agathanggelou A, Nicholls JM. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Sem Cancer Biol 1996; 7: 165-174.
29. Lespagnard L, Cochaux P, Larsimont D, Degeyter M, Velu T, Heimann R. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol 1995; 103: 449-452.
30. Bonnet M, Guinebretiere J-MG, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999; 91: 1376-1381.
31. Chu PG, Chang KL, Chen Y-Y, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001; 159: 571-578.
32. Herrman K, Niedobitek G. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res 2003; 5: R13-R17.
33. Yates J, Waren N, Reisman D, Sugden B. A cis-acting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 1984; 81: 3806-3810.
34. Murray PG, Niedobitek G, Kremmer E, et al. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol 1996; 178: 44-47.
35. International Agency for Research on Cancer. Hepatitis Viruses, vol 59. WHO: Lyon, 1994.
36. Sugawara Y, Makuuchi M, Takada K. Detection of Epstein-Barr virus in hepatocellular carcinoma from hepatitis C-positive patients. Scand J Gastroenterol 2000; 35: 981-984.
37. Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato E. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 1993; 143: 1263-1268.
38. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
39. Junying J, Herrmann K, Davies G, et al. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology; in press.
40. Chu PG, Chen YY, Chen W, Weiss LM. No direct role for Epstein-Barr virus in American hepatocellular carcinoma. Am J Pathol 2001; 159: 1287-1292.
41. Osato T, Imai S. Epstein-Barr virus and gastric carcinoma. Sem Cancer Biol 1996; 7: 175-182.
42. Saemundsen AK, Albeck H, Hansen JPH, et al. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. Br J Cancer 1982; 46: 721-728.
43. Hamilton-Dutoit SJ, Hamilton-Therkildsen M, Nielsen NH, Jensen H, Hensen JPH, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenland Eskimos: demonstration of Epstein-Barr virus DNA by in situ hybridization. Hum Pathol 1991; 22: 811-815.
44. Tsai CC, Chen CL, Hsu HC. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol 1996; 27: 258-262.
45. Butler AE, Colby TV, Waeiss L, Lombard C. Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 1989; 13: 632-639.
46. Wong MP, Chung LP, Yuen ST, Chan SY, Wang E, Fu KH. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J Pathol 1995; 177: 233-240.
47. Leyvraz S, Henle W, Cahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985; 312: 1296-1299.
48. Hartmann C-A, Roth C, Minck C, Niedobitek G. Thymic carcinoma. Report of five cases and review of the literature. J Cancer Res Clin Oncol 1990; 116: 69-82.
49. Borisch B, Kirchner T, Marx A, Müller-Hermelink HK. Absence of the Epstein-Barr virus genome in the normal thymus, thymic epithelial tumors, and thymic lymphoid hyperplasia in a European population. Virchows Arch B Cell Pathol 1990; 59: 359-365.
50. Mann RB, Wu TC, MacMahon EM, Ling Y, Charache P, Ambinder RF. In situ localization of Epstein-Barr virus in thymic carcinoma. Mod Pathol 1992; 5: 363-366.
51. Wu T-C, Kuo T-T. Study of Epstein-Barr virus early RNA 1 (EBER1) expression by in situ hybridization in thymic epithelial tumors of Chinese patients in Taiwan. Hum Pathol 1993; 24: 235-238.
52. Mori M, Watanabe M, Tanaka S, Mimori K, Kuwano H, Sugimachi K. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med 1994; 118: 998-1001.
53. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992; 140: 769-774.
54. Rowlands DC, Ito M, Mangham DC, et al. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 1993; 68: 1014-1019.
55. Yuen ST, Chung LP, Leung SY, Luk ISC, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Puthol 1994; 18: 1158-1163.
56. Leung SY, Yuen ST, Chung LP, Kwong WK, Wong MP, Chan SY. Epstein-Barr virus is present in a wide histological spectrum of sinonasal carcinomas. Am J Surg Pathol 1995; 19: 994-1001.
57. Gallo O, Di Lollo S, Graziani P, Gallina E, Baroni G. Detection of Epstein-Barr virus genome in sinonasal undifferentiated carcinoma by use of in situ hybridization. Otolaryngol Head Neck Surg 1995; 112: 659-664.
58. Lopategui JR, Gaffey MJ, Frierson HF, et al. Detection of Epstein-Barr viral RNA in sinonasal undifferentiated carcinoma from Western and Asian patients. Am J Surg Pathol 1994; 18: 391-398.
59. Landers RJ, O'Leary JJ, Crowley M, et al. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol 1993; 46: 931-935.
60. Hilton DA, Brown LJR, Pringle JH, Nandha H. Absence of Epstein-Barr virus in carcinoma of the cervix. Cancer 1993; 72: 1946-1948.
61. Payne S, Kernohan NM, Walker F. Absence of in situ hybridization evidence for latent- or lytic-phase Epstein-Barr virus infection of preinvasive squamous lesions of the cervix. J Pathol 1995; 176: 221-226.
62. Conway EJ, Hudnall SD, Lazarides A, Bahler A, Fraire AE, Cagle PT. Absence of evidence for an etiologic role for Epstein-Barr virus in neoplasms of the lung and pleura. Mod Pathol 1996; 9: 491-495.